Wesana Health Holdings Inkomsten in het verleden
Verleden criteriumcontroles 0/6
Wesana Health Holdings has been growing earnings at an average annual rate of 27.9%, while the Pharmaceuticals industry saw earnings growing at 13.1% annually. Revenues have been declining at an average rate of 136.5% per year.
Belangrijke informatie
27.9%
Groei van de winst
67.1%
Groei van de winst per aandeel
| Pharmaceuticals Groei van de industrie | 7.3% |
| Inkomstengroei | -136.5% |
| Rendement op eigen vermogen | n/a |
| Nettomarge | n/a |
| Laatste winstupdate | 30 Jun 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Opbrengsten en kosten
Hoe Wesana Health Holdings geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 0 | -2 | 1 | 0 |
| 31 Mar 24 | 0 | -2 | 1 | 0 |
| 31 Dec 23 | 0 | -2 | 1 | 0 |
| 30 Sep 23 | 0 | -3 | 2 | 0 |
| 30 Jun 23 | 0 | 0 | 0 | 0 |
| 31 Mar 23 | 0 | -1 | 1 | 0 |
| 31 Dec 22 | 0 | -3 | 3 | 0 |
| 30 Sep 22 | 0 | -2 | 4 | 0 |
| 30 Jun 22 | 0 | -2 | 4 | 0 |
| 31 Mar 22 | 0 | -6 | 5 | 0 |
| 31 Dec 21 | 0 | -6 | 5 | 0 |
| 30 Sep 21 | 0 | -6 | 3 | 0 |
| 30 Jun 21 | 0 | -8 | 4 | 0 |
| 31 Mar 21 | 0 | -3 | 1 | 0 |
| 31 Dec 20 | 0 | 0 | 0 | 0 |
Kwaliteitswinsten: DDX is currently unprofitable.
Groeiende winstmarge: DDX is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: DDX is unprofitable, but has reduced losses over the past 5 years at a rate of 27.9% per year.
Versnelling van de groei: Unable to compare DDX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: DDX is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (28.7%).
Rendement op eigen vermogen
Hoge ROE: DDX's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.